Clinical Trial Update: Treatment of Chemotherapy Refractory Human Epidermalgrowth Factor Receptor-2( HER-2) Positive Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update from Chinese PLA General Hospital evaluating treatment of chemotherapy-refractory HER2-positive advanced solid tumors. The sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Advanced HER-2 Positive Solid Tumors, Chemotherapy Refactory | Phase 1, Phase 2 | Status: UNKNOWN